Computational Methods for Identifying Similar Diseases

Although our knowledge of human diseases has increased dramatically, the molecular basis, phenotypic traits, and therapeutic targets of most diseases still remain unclear. An increasing number of studies have observed that similar diseases often are caused by similar molecules, can be diagnosed by s...

Full description

Saved in:
Bibliographic Details
Main Authors: Liang Cheng (Author), Hengqiang Zhao (Author), Pingping Wang (Author), Wenyang Zhou (Author), Meng Luo (Author), Tianxin Li (Author), Junwei Han (Author), Shulin Liu (Author), Qinghua Jiang (Author)
Format: Book
Published: Elsevier, 2019-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_24f5caa78cde40a58af0908dfeb37ee0
042 |a dc 
100 1 0 |a Liang Cheng  |e author 
700 1 0 |a Hengqiang Zhao  |e author 
700 1 0 |a Pingping Wang  |e author 
700 1 0 |a Wenyang Zhou  |e author 
700 1 0 |a Meng Luo  |e author 
700 1 0 |a Tianxin Li  |e author 
700 1 0 |a Junwei Han  |e author 
700 1 0 |a Shulin Liu  |e author 
700 1 0 |a Qinghua Jiang  |e author 
245 0 0 |a Computational Methods for Identifying Similar Diseases 
260 |b Elsevier,   |c 2019-12-01T00:00:00Z. 
500 |a 2162-2531 
500 |a 10.1016/j.omtn.2019.09.019 
520 |a Although our knowledge of human diseases has increased dramatically, the molecular basis, phenotypic traits, and therapeutic targets of most diseases still remain unclear. An increasing number of studies have observed that similar diseases often are caused by similar molecules, can be diagnosed by similar markers or phenotypes, or can be cured by similar drugs. Thus, the identification of diseases similar to known ones has attracted considerable attention worldwide. To this end, the associations between diseases at the molecular, phenotypic, and taxonomic levels were used to measure the pairwise similarity in diseases. The corresponding performance assessment strategies for these methods involving the terms "category-based," "simulated-patient-based," and "benchmark-data-based" were thus further emphasized. Then, frequently used methods were evaluated using a benchmark-data-based strategy. To facilitate the assessment of disease similarity scores, researchers have designed dozens of tools that implement these methods for calculating disease similarity. Currently, disease similarity has been advantageous in predicting noncoding RNA (ncRNA) function and therapeutic drugs for diseases. In this article, we review disease similarity methods, evaluation strategies, tools, and their applications in the biomedical community. We further evaluate the performance of these methods and discuss the current limitations and future trends for calculating disease similarity. Keywords: disease similarity, phenotypic traits, molecular basis, ncRNA function, therapeutic drugs 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Molecular Therapy: Nucleic Acids, Vol 18, Iss , Pp 590-604 (2019) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2162253119302665 
787 0 |n https://doaj.org/toc/2162-2531 
856 4 1 |u https://doaj.org/article/24f5caa78cde40a58af0908dfeb37ee0  |z Connect to this object online.